The microbiome-restorative potential of ibezapolstat for the treatment of Clostridioides difficile infection is predicted through variant PolC-type DNA polymerase III in Lachnospiraceae and Oscillospiraceae.

IF 4.1 2区 医学 Q2 MICROBIOLOGY Antimicrobial Agents and Chemotherapy Pub Date : 2025-02-21 DOI:10.1128/aac.01679-24
Jacob K McPherson, Julian G Hurdle, Matthew L Baker, Tahir Hussain, Ashok Kumar, Kevin W Garey
{"title":"The microbiome-restorative potential of ibezapolstat for the treatment of <i>Clostridioides difficile</i> infection is predicted through variant PolC-type DNA polymerase III in Lachnospiraceae and Oscillospiraceae.","authors":"Jacob K McPherson, Julian G Hurdle, Matthew L Baker, Tahir Hussain, Ashok Kumar, Kevin W Garey","doi":"10.1128/aac.01679-24","DOIUrl":null,"url":null,"abstract":"<p><p>Ibezapolstat (IBZ), a first-in-class antibiotic targeting the PolC-type DNA polymerase III alpha-subunit (PolC) in low G + C bacteria, is in clinical development for the treatment of <i>Clostridioides difficile</i> infection (CDI). In the phase 2 trials, IBZ had potent activity against <i>C. difficile</i> while sparing or causing regrowth of Lachnospiraceae, Oscillospiraceae, and Erysipelotrichales, common commensal low G + C bacteria. The purpose of this study was to utilize <i>in silico</i> approaches to better interpret the narrower than expected IBZ spectrum of activity. IBZ susceptibility to human commensal microbiota was predicted using genomic analysis and PolC phylogenetic tree construction in relation to <i>C. difficile</i> and commensal low G + C bacteria. Protein structure prediction was performed using AlphaFold2 and binding pocket homology modeling was performed using Schrodinger Maestro and UCSF ChimeraX. An amino acid phylogenetic tree identified certain residues that were phylogenetically variant in Lachnospiraceae, Oscillospiraceae, and Erysipelotrichales and conserved in <i>C. difficile</i>. Chemical modeling showed that these residues ablated key PolC•IBZ predicted interactions including two lysine \"<i>gates</i>\" (<sub>CdiPolC</sub>Lys1148 and <sub>CdiPolC</sub>Lys1327) that \"<i>latch</i>\" onto the compound; an \"<i>anchoring</i>\" interaction (<sub>CdiPolC</sub>Thr1331) to the central moiety; and a stabilized set of <i>C. difficile</i> sensitizer residues (<sub>CdiPolC</sub>Thr1291 and <sub>CdiPolC</sub>Lys1292) that resulted in the prolonged inhibition of a catalytic residue (<sub>CdiPolC</sub>Asp1090). The observed IBZ sparing of Lachnospiraceae, Oscillospiraceae, and Erysipelotrichaceae/Coprobacillaceae was predicted using <i>in silico</i> techniques. Further studies that confirm a PolC structural basis for the IBZ narrower than expected activity are needed to confirm these <i>in silico</i> phylogenetic and chemical modeling data.</p>","PeriodicalId":8152,"journal":{"name":"Antimicrobial Agents and Chemotherapy","volume":" ","pages":"e0167924"},"PeriodicalIF":4.1000,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobial Agents and Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1128/aac.01679-24","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Ibezapolstat (IBZ), a first-in-class antibiotic targeting the PolC-type DNA polymerase III alpha-subunit (PolC) in low G + C bacteria, is in clinical development for the treatment of Clostridioides difficile infection (CDI). In the phase 2 trials, IBZ had potent activity against C. difficile while sparing or causing regrowth of Lachnospiraceae, Oscillospiraceae, and Erysipelotrichales, common commensal low G + C bacteria. The purpose of this study was to utilize in silico approaches to better interpret the narrower than expected IBZ spectrum of activity. IBZ susceptibility to human commensal microbiota was predicted using genomic analysis and PolC phylogenetic tree construction in relation to C. difficile and commensal low G + C bacteria. Protein structure prediction was performed using AlphaFold2 and binding pocket homology modeling was performed using Schrodinger Maestro and UCSF ChimeraX. An amino acid phylogenetic tree identified certain residues that were phylogenetically variant in Lachnospiraceae, Oscillospiraceae, and Erysipelotrichales and conserved in C. difficile. Chemical modeling showed that these residues ablated key PolC•IBZ predicted interactions including two lysine "gates" (CdiPolCLys1148 and CdiPolCLys1327) that "latch" onto the compound; an "anchoring" interaction (CdiPolCThr1331) to the central moiety; and a stabilized set of C. difficile sensitizer residues (CdiPolCThr1291 and CdiPolCLys1292) that resulted in the prolonged inhibition of a catalytic residue (CdiPolCAsp1090). The observed IBZ sparing of Lachnospiraceae, Oscillospiraceae, and Erysipelotrichaceae/Coprobacillaceae was predicted using in silico techniques. Further studies that confirm a PolC structural basis for the IBZ narrower than expected activity are needed to confirm these in silico phylogenetic and chemical modeling data.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Ibezapolstat(IBZ)是一种针对低G+C细菌中PolC型DNA聚合酶IIIα-亚基(PolC)的首创抗生素,目前正处于治疗艰难梭菌感染(CDI)的临床开发阶段。在 2 期试验中,IBZ 对艰难梭菌具有很强的活性,同时可防止或导致常见的低 G + C 共生菌 Lachnospiraceae、Oscillospiraceae 和 Erysipelotrichales 重新生长。本研究的目的是利用硅学方法更好地解释比预期更窄的 IBZ 活性谱。通过基因组分析和 PolC 系统发生树的构建,结合艰难梭菌和低 G + C 共生菌,预测了 IBZ 对人类共生微生物群的敏感性。使用 AlphaFold2 进行了蛋白质结构预测,并使用 Schrodinger Maestro 和 UCSF ChimeraX 进行了结合口袋同源建模。氨基酸系统发生树确定了某些残基,这些残基在 Lachnospiraceae、Oscillospiraceae 和 Erysipelotrichales 中存在系统发育变异,而在艰难梭菌中是保守的。化学建模显示,这些残基消减了 PolC-IBZ 预测的关键相互作用,包括两个赖氨酸 "门"(CdiPolCLys1148 和 CdiPolCLys1327),可 "锁住 "化合物;与中心分子的 "锚定 "相互作用(CdiPolCThr1331);以及一组稳定的艰难梭菌敏化剂残基。CdiPolCThr1291和CdiPolCLys1292),从而延长了对催化残基(CdiPolCAsp1090)的抑制。观察到的 Lachnospiraceae、Oscillospiraceae 和 Erysipelotrichaceae/Coprobacillaceae 对 IBZ 的稀释是利用硅学技术预测的。需要进一步研究证实 PolC 结构是 IBZ 比预期活性更窄的基础,以证实这些硅系统发育和化学建模数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
10.00
自引率
8.20%
发文量
762
审稿时长
3 months
期刊介绍: Antimicrobial Agents and Chemotherapy (AAC) features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy.
期刊最新文献
Antimicrobial susceptibility of Stenotrophomonas maltophilia from United States medical centers (2019-2023). Clinical outcomes and pharmacokinetics/pharmacodynamics of intravenous polymyxin B treatment for various site carbapenem-resistant gram-negative bacterial infections: a prospective observational multicenter study. Enhanced suppression of Stenotrophomonas maltophilia by a three-phage cocktail: genomic insights and kinetic profiling. Prevalence and mortality associated with multidrug-resistant infections in adult intensive care units in Argentina (PREV-AR). Genomic analyses reveal high diversity and rapid evolution of Pichia kudriavzevii within a neonatal intensive care unit in Delhi, India.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1